Completed PHASE4 INTERVENTIONAL 1-arm NCT04188106

Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment (HAVE)

Sponsor: Foundation for a Smoke Free World INC

Conditions Nausea Sleep Disturbance Smoking Cessation Stress

Interventions Hydroxyzine Pill Varenicline Pill

Updated 6 times since 2020 Last updated: Feb 2, 2023 Started: Jun 17, 2019 Primary completion: Dec 15, 2019 Completion: Dec 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Nausea and Sleep Disturbance, this trial is completed. The trial is conducted by Foundation for a Smoke Free World INC and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2023 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Apr 2023 [monthly]

Completed PHASE4
Apr 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2020 — Apr 2020 [monthly]

Active Not Recruiting PHASE4

First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Foundation for a Smoke Free World INC
Rose Research Center, LLC

Data source: Rose Research Center, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlotte, United States
• Raleigh, United States